Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
Hoffmann-La Roche
Institut Bergonié
Bayer
ViroMissile, Inc.
Dana-Farber Cancer Institute
Essen Biotech
Angiex, Inc.
MacroGenics
City of Hope Medical Center
Var2 Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Bristol-Myers Squibb
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Lantheus Medical Imaging
Jonsson Comprehensive Cancer Center
University of Pittsburgh
NextPoint Therapeutics, Inc.
Cancer Research UK
Elevation Oncology
Stanford University
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Stanford University
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Peking University
European Organisation for Research and Treatment of Cancer - EORTC
NantCell, Inc.
Zhejiang Provincial People's Hospital
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Charite University, Berlin, Germany
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Emory University
pharmaand GmbH
Kineta Inc.
Tempest Therapeutics
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology